OCTAGON RESEARCH SOLUTIONS ATTRACTS $3 MILLION IN SECOND ROUND FUNDING

WAYNE, PA - April 1, 2005 - Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, announced today that the Company has completed a $3 million second round of funding led by Edison Venture Fund.  The proceeds will accelerate development, marketing and sales of Octagon's ViewPoint™ process management solution.  The Company completed a first round of funding for $3.8 million in February 2003, also led by Edison Venture Fund.

"Edison has been a valued equity partner for several years," said James C. Walker, president & CEO of Octagon.  "This additional funding will help us continue our commitment to providing our clients with superior solutions that resonate across the entire R&D lifecycle."

Octagon has successfully assisted clients to file over 90 electronic submissions to the FDA and similar agencies worldwide.  The Company's solutions streamline processes to create systemic improvements across the drug development lifecycle.  Octagon serves over 65 clients including AstraZeneca, Barr Laboratories, Endo Pharmaceuticals, Johnson & Johnson, Sanofi-Synthelabo and Wyeth.

"We are excited to be able to continue our partnership with Octagon.  Our additional investment in Octagon is a strong endorsement of its technology, management team and explosive growth.  Our continued guidance combined with Octagon's strong management team will serve as the foundation for a company that will continue to provide innovative solutions to the pharmaceutical and biotechnology industries," said Bruce Luehrs, Edison General Partner.

About Octagon Research Solutions, Inc.

Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and creative use of technology. Octagon is headquartered in King of Prussia, PA, with an office in Boston, MA. For more information please visit www.octagonresearch.com.

About Edison Venture Fund

Established in 1986, Edison partners with entrepreneurs, service providers and other financing sources to build successful companies. Edison provides capital and value-added services to expansion stage ($5 to 20 million revenue), information technology businesses. Initial investments range from $3 to 5 million. Edison typically serves as a sole or lead investor in financings up to $10 million. In addition to providing expansion capital, Edison funds management buyouts, recapitalizations, spinouts and secondary stock purchases. Edison's 18 investment professionals are based in Lawrenceville, NJ, Bala Cynwyd, PA, and McLean, VA. Industry specialties include application software, education, financial services, healthcare & pharmaceutical IT and electronics. Edison's successes include ACT!, Axent, Best Software, BTG, Dendrite, Gain Capital, Marcam, Princeton Financial, Visual Networks, Vocus and many other information technology leaders, which have a combined market value exceeding $5 billion. Edison currently has $420 million under management and is actively making new investments.

Company Website: http://www.edisonventure.com